OTHER 2015 WEBINARS!
Transcription
OTHER 2015 WEBINARS!
Liver Cancer Webinar Series: What You Need to Know Presented by the Hepatitis B Foundation in collaboration with Blue Faery: The Adrienne Wilson Liver Cancer Association Did You Know? Liver cancer is the 2nd leading cause of cancerrelated deaths and the 6th most common cancer worldwide. But if detected early, liver cancer can be treated or cured with liver surgery or transplantation. • • • 2015 WEBINARS Presented for free by the Hepatitis B Foundation Clinical Trials in Liver Cancer Expert Speakers: Treatments for liver cancer are available. New therapies are being studied in clinical trials. Support services can help families facing liver cancer. Learn More About Liver Cancer Jill McNair Director of Education, Outreach and Community Support The Center for Information & Study on Clinical Research Participation (CISCRP) Join the Hepatitis B Foundation’s webinar series on liver cancer to learn about treatment options, clinical trials, and support services Katelyn Levy, BS Visit www.LiverCancerConnect.org A patient-focused resource with accurate information and valuable support Clinical Research Coordinator Gastroenterology & Hepatology Johns Hopkins Suburban Hospital Date: Wednesday, May 27 Time: 1:30 pm EDT; 10:30 am PDT To register, click here OTHER 2015 WEBINARS! Support Services for Families Facing Liver Cancer Expert Speakers: Karla Pillote, MSN, CANP, and Andrea Wilson, MPW Date: Wednesday, June 3 Time: 1:30 pm EDT; 10:30 am PDT To register, click here Treatment Options for Liver Cancer Expert Speaker: Robert G. Gish, MD View webinar
Similar documents
Fatty Liver Disease Global Clinical Trials Review Industry Key Trends, Size, Growth, Shares and Forecast Research Report
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that has been shown to progress to cirrhosis and hepatocellular carcinoma. This article reviews the prevalence of NAFLD and the factors associated this disorder, and with the more advanced stages of NAFLD.
More informationWhy is FerriScan superior to other tests in the estimation... 1. Advantages of FerriScan over serum ferritin
More information
Non Alcoholic Fatty Liver Disease (NAFLD) Market Size, Share, Pipeline Review, H1 2016: Radiant Insights
Global Markets Direct's, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2016', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/non-alcoholic-fatty-liver-disease-nafld-pipeline-review-h1-2016
More information